References: Prevention of infection in patients with cirrhosis and upper gastrointestinal bleeding

  • Biggins SW, Angeli P, Garcia-Tsao G, Gines P, Ling SC, Nadim MK, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74(2):1014-48. https://www.ncbi.nlm.nih.gov/pubmed/33942342
  • Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010;2010(9):CD002907. https://www.ncbi.nlm.nih.gov/pubmed/20824832
  • European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. J Hepatol 2018;69(5):1207. https://www.ncbi.nlm.nih.gov/pubmed/30172388
  • Fortune B, Garcia-Tsao G. Current Management Strategies for Acute Esophageal Variceal Hemorrhage. Curr Hepatol Rep 2014;13(1):35-42. https://www.ncbi.nlm.nih.gov/pubmed/24955303
  • Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65(1):310-35. https://www.ncbi.nlm.nih.gov/pubmed/27786365
  • Jia Y, Dwivedi A, Elhanafi S, Ortiz A, Othman M, Zuckerman M. Low risk of bacteremia after endoscopic variceal therapy for esophageal varices: a systematic review and meta-analysis. Endosc Int Open 2015;3(5):E409-17. https://www.ncbi.nlm.nih.gov/pubmed/26528494
  • Kuo MT, Yang SC, Lu LS, Hsu CN, Kuo YH, Kuo CH, et al. Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease. BMC Gastroenterol 2015;15:61. https://www.ncbi.nlm.nih.gov/pubmed/26268474
  • Lee TH, Huang CT, Lin CC, Chung CS, Lin CK, Tsai KC. Similar rebleeding rate in 3-day and 7-day intravenous ceftriaxone prophylaxis for patients with acute variceal bleeding. J Formos Med Assoc 2016;115(7):547-52. https://www.ncbi.nlm.nih.gov/pubmed/26899745
  • Moon AM, Dominitz JA, Ioannou GN, Lowy E, Beste LA. Use of Antibiotics Among Patients With Cirrhosis and Upper Gastrointestinal Bleeding Is Associated With Reduced Mortality. Clin Gastroenterol Hepatol 2016;14(11):1629-37 e1. https://www.ncbi.nlm.nih.gov/pubmed/27311621
  • Runyon BA. Management of adult patients with ascites due to cirrhosis: Update 2012 [practice guideline]. Alexandria, Virginia: American Association for the Study of Liver Diseases; 2012. https://www.aasld.org/practice-guidelines
  • Shneider BL, Bosch J, de Franchis R, Emre SH, Groszmann RJ, Ling SC, et al. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant 2012;16(5):426-37. https://www.ncbi.nlm.nih.gov/pubmed/22409296
  • Tandon P, Abraldes JG, Keough A, Bastiampillai R, Jayakumar S, Carbonneau M, et al. Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on Child-Pugh class, and effects of antibiotics. Clin Gastroenterol Hepatol 2015;13(6):1189-96 e2. https://www.ncbi.nlm.nih.gov/pubmed/25460564